AbbVie is buying the developer of treatments for schizophrenia and other neuroscience diseases.
Investors were disappointed by the cloud-based software service company's latest financial update.
The online pet store trimmed its revenue forecast for the year.
The wine company's fiscal first-quarter profit and revenue fell short of analysts' forecasts.
The maker of software for analyzing intercepted communications reported strong third-quarter financial results.
The chipmaker's third-quarter earnings and revenue beat
The airline raised its revenue forecast for the year.
The maker of electrical components for the auto and computer industries slashed its earnings forecast for the year.
Copyright 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
, source